Advanced genetic engineering

Glover, Stanford (2012) Advanced genetic engineering. The English Press, Delhi, India. ISBN 978-81-323-4597-8

[thumbnail of StanfordGlover2012_AdvancedGeneticEngineering.pdf]
Preview
Text
StanfordGlover2012_AdvancedGeneticEngineering.pdf - Published Version

Download (2MB) | Preview

Abstract

Genetic engineering, also called genetic modification, is the direct human manipulation of an organism's genetic material in a way that does not occur under natural conditions. It involves the use of recombinant DNA techniques, but does not include traditional animal and plant breeding or mutagenesis. Any organism that is generated using these techniques is considered to be a genetically modified organism. The first organisms genetically engineered were bacteria in 1973 and then mice in 1974. Insulin producing bacteria were commercialized in 1982 and genetically modified food has been sold since 1994. The most common form of genetic engineering involves the insertion of new genetic material at an unspecified location in the host genome. This is accomplished by isolating and copying the genetic material of interest, generating a construct containing all the genetic elements for correct expression, and then inserting this construct into the host organism. Other forms of genetic engineering include gene targeting and knocking out specific genes via engineered nucleases such as zinc finger nucleases or engineered homing endonucleases. Genetic engineering techniques have been applied in numerous fields including research, biotechnology, and medicine. Medicines such as insulin and human growth hormone are now produced in bacteria, experimental mice such as the oncomouse and the knockout mouse are being used for research purposes and insect resistant and/or herbicide tolerant crops have been commercialized. Genetically engineered plants and animals capable of producing biotechnology drugs more cheaply than current methods (called pharming) are also being developed and in 2009 the FDA approved the sale of the pharmaceutical protein antithrombin produced in the milk of genetically engineered goats.

Item Type: Book
Subjects: Q Science > QH Natural history > QH426 Genetics
Divisions: Electronic Books
Depositing User: Practical Student 02
Date Deposited: 10 Apr 2022 07:30
Last Modified: 31 Jul 2022 04:03
URI: http://odlsystem2.utm.my/id/eprint/2975

Actions (login required)

View Item View Item